Nu Skin Enterprises, Inc is a household & personal products business based in the US. Nu Skin Enterprises shares (NUS) are listed on the NYSE and all prices are listed in US Dollars. Nu Skin Enterprises employs 5,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Nu Skin Enterprises
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NUS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Nu Skin Enterprises stock price (NYSE: NUS)Use our graph to track the performance of NUS stocks over time.
Nu Skin Enterprises shares at a glance
|Latest market close||$60.16|
|52-week range||$42.93 - $62.97|
|50-day moving average||$56.19|
|200-day moving average||$55.51|
|Wall St. target price||$66.67|
|Dividend yield||$1.505 (2.78%)|
|Earnings per share (TTM)||$4.21|
Buy Nu Skin Enterprises shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Nu Skin Enterprises stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Nu Skin Enterprises price performance over time
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||5.62%|
|3 months (2021-05-04)||15.47%|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
Is Nu Skin Enterprises under- or over-valued?
Valuing Nu Skin Enterprises stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nu Skin Enterprises's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nu Skin Enterprises's P/E ratio
Nu Skin Enterprises's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Nu Skin Enterprises shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Nu Skin Enterprises's PEG ratio
Nu Skin Enterprises's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.35. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Nu Skin Enterprises's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Nu Skin Enterprises's EBITDA
Nu Skin Enterprises's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $357.2 million.
The EBITDA is a measure of a Nu Skin Enterprises's overall financial performance and is widely used to measure a its profitability.
Nu Skin Enterprises financials
|Revenue TTM||$2.7 billion|
|Operating margin TTM||10.36%|
|Gross profit TTM||$1.9 billion|
|Return on assets TTM||9.6%|
|Return on equity TTM||26.2%|
|Market capitalisation||$2.7 billion|
TTM: trailing 12 months
Shorting Nu Skin Enterprises shares
There are currently 2.7 million Nu Skin Enterprises shares held short by investors – that's known as Nu Skin Enterprises's "short interest". This figure is 1.9% down from 2.7 million last month.
There are a few different ways that this level of interest in shorting Nu Skin Enterprises shares can be evaluated.
Nu Skin Enterprises's "short interest ratio" (SIR)
Nu Skin Enterprises's "short interest ratio" (SIR) is the quantity of Nu Skin Enterprises shares currently shorted divided by the average quantity of Nu Skin Enterprises shares traded daily (recently around 806716.918429). Nu Skin Enterprises's SIR currently stands at 3.31. In other words for every 100,000 Nu Skin Enterprises shares traded daily on the market, roughly 3310 shares are currently held short.
However Nu Skin Enterprises's short interest can also be evaluated against the total number of Nu Skin Enterprises shares, or, against the total number of tradable Nu Skin Enterprises shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nu Skin Enterprises's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Nu Skin Enterprises shares in existence, roughly 50 shares are currently held short) or 0.0576% of the tradable shares (for every 100,000 tradable Nu Skin Enterprises shares, roughly 58 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Nu Skin Enterprises.
Find out more about how you can short Nu Skin Enterprises stock.
Nu Skin Enterprises share dividends
Dividend payout ratio: 44.54% of net profits
Recently Nu Skin Enterprises has paid out, on average, around 44.54% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Nu Skin Enterprises shareholders could enjoy a 2.8% return on their shares, in the form of dividend payments. In Nu Skin Enterprises's case, that would currently equate to about $1.505 per share.
While Nu Skin Enterprises's payout ratio might seem fairly standard, it's worth remembering that Nu Skin Enterprises may be investing much of the rest of its net profits in future growth.
Nu Skin Enterprises's most recent dividend payout was on 8 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 26 May 2021 (the "ex-dividend date").
Nu Skin Enterprises share price volatility
Over the last 12 months, Nu Skin Enterprises's shares have ranged in value from as little as $42.9272 up to $62.968. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nu Skin Enterprises's is 1.1823. This would suggest that Nu Skin Enterprises's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nu Skin Enterprises overview
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
Stocks similar to Nu Skin Enterprises
Nu Skin Enterprises in the news
How Many Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Did Insiders Buy, In The Last Year?
Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note
Price To Earnings Ratio Insights For Nu Skin Enterprises
Frequently asked questionsWhat percentage of Nu Skin Enterprises is owned by insiders or institutions?
Currently 1.579% of Nu Skin Enterprises shares are held by insiders and 82.602% by institutions. How many people work for Nu Skin Enterprises?
Latest data suggests 5,000 work at Nu Skin Enterprises. When does the fiscal year end for Nu Skin Enterprises?
Nu Skin Enterprises's fiscal year ends in December. Where is Nu Skin Enterprises based?
Nu Skin Enterprises's address is: 75 West Center Street, Provo, UT, United States, 84601 What is Nu Skin Enterprises's ISIN number?
Nu Skin Enterprises's international securities identification number is: US67018T1051 What is Nu Skin Enterprises's CUSIP number?
Nu Skin Enterprises's Committee on Uniform Securities Identification Procedures number is: 67018T105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert